[{"Assets_0_Q3_USD":"10521662000.0","CIK":"1593034","CommonStockSharesConverted_0_Q3_shares":"224288553.0","CommonStockSharesOutstanding_0_Q3_shares":"224288553.0","Country":"Ireland","EarningsPerShareBasic_1_Q3_USD":"-0.77","EarningsPerShareBasic_3_Q3_USD":"-3.3","EarningsPerShareDiluted_1_Q3_USD":"-0.77","EarningsPerShareDiluted_3_Q3_USD":"-3.3","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"196992000.0","NetIncomeLossConverted_1_Q3_USD":"-173205000.0","NetIncomeLossConverted_3_Q3_USD":"-739561000.0","OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q3_USD":"745466000.0","RevenuesConverted_3_Q3_USD":"2160689000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"-219459000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"224132000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"223829000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"224132000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"223829000.0","filed":"20181108","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"ENDO INTERNATIONAL PLC","period":"20180930","qtrs":"0","uom":"USD"}]